These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3400215)

  • 1. [Histotopographic ratio of gastric mucosa cells in patients with peptic ulcer after treatment].
    Gaĭdichuk SF; Zazhaeva VV
    Vrach Delo; 1988 Apr; (4):27-9. PubMed ID: 3400215
    [No Abstract]   [Full Text] [Related]  

  • 2. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell kinetics of the gastric mucosa of patients treated with omeprazole.
    Biasco G; Mordenti P; Brandi G; Paganelli GM; Santucci R; Miglioli M
    Am J Gastroenterol; 1996 Mar; 91(3):621-2. PubMed ID: 8633536
    [No Abstract]   [Full Text] [Related]  

  • 4. Gastric cyto-secretory correlations in peptic ulcer.
    Testino G; Cornaggia M; Valentini M
    Hepatogastroenterology; 1999; 46(28):2710-2. PubMed ID: 10522069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between mast cells/parietal cells and maximal/basal acid output ratio in chronic gastritis.
    Biernacka D; Muszynski J; Tomaszewska A; Moskalewski S
    Res Exp Med (Berl); 2000 Dec; 200(1):35-41. PubMed ID: 11197920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical trial of Alcid V in peptic ulcer therapy].
    Vŭrbanov G; Rusinov E; Danev I; Glinkova V; Panecheva K
    Vutr Boles; 1981; 20(5):27-34. PubMed ID: 7034375
    [No Abstract]   [Full Text] [Related]  

  • 7. Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole.
    Hage E; Hendel L; Gustafsen J; Hendel J
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):781-9. PubMed ID: 12811309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in gastric ECL cells and parietal cells after long-term administration of high-dose omeprazole to patients with Barrett's esophagus.
    Nishi T; Makuuchi H; Weinstein WM
    Tokai J Exp Clin Med; 2005 Jul; 30(2):117-21. PubMed ID: 16146202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The status of the structure of the gastric mucosa in patients with peptic ulcer].
    Pleshkaneva AF
    Ter Arkh; 1967 Nov; 39(11):89-91. PubMed ID: 5611743
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug treatment of peptic ulcer syndrome.
    Fielding JF
    Ir Med J; 1982 Oct; 75(10):379-82. PubMed ID: 7174254
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of pentagastrin on tissue culture of gastric and duodenal mucosa originating from patients with ulcer disease].
    Kleczkowska A; Kubień E; Wanicka A; Szafran H; Popiela T
    Pol Tyg Lek; 1975 Dec; 30(50):2081-4. PubMed ID: 1197098
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment with lansoprazole also induces hypertrophy of the parietal cells of the stomach.
    Stolte M; Meining A; Seifert E; Alexandridis T
    Pathol Res Pract; 2000; 196(1):9-13. PubMed ID: 10674267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptic ulcer disease.
    Hawker P
    Practitioner; 1989 May; 233(1469):769-70, 773. PubMed ID: 2602318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biopsy study of the gastric mucosa in patients gastrectomized for peptic ulcer].
    Tomat E
    Friuli Med; 1967; 22(2):305-24. PubMed ID: 5607697
    [No Abstract]   [Full Text] [Related]  

  • 15. [Controversy and trends in ulcer therapy. 1: Treatment of ulcer manifestation].
    Berndt H
    Z Arztl Fortbild (Jena); 1993 Aug; 87(8):635-42. PubMed ID: 8379202
    [No Abstract]   [Full Text] [Related]  

  • 16. Gastric chief cell mass in duodenal ulcer.
    Perasso A; Testino G; Ansaldi F
    Acta Gastroenterol Latinoam; 1993; 23(1):5-11. PubMed ID: 8237265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptic ulcer disease, cytoprotection, and prostaglandins.
    Fiske SC
    Arch Intern Med; 1988 Oct; 148(10):2112-3. PubMed ID: 3140751
    [No Abstract]   [Full Text] [Related]  

  • 18. [The clinico-histochemical validation of the differential use of calcium antagonists in gastroduodenal ulcers].
    Birg NA
    Ter Arkh; 1994; 66(2):48-51. PubMed ID: 8160145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologically different biopsy specimens of the human gastric mucosa. I. The use of enzymatic cell isolation for quantitative determination of parietal cells.
    Ruoff HJ; Leyhe T; Eichhorst UB; Haile EM; Malchow H
    Pharmacology; 1986; 33(3):121-30. PubMed ID: 3018801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphology and function of the parietal cells after proximal selective vagotomy in duodenal ulcer patients.
    Aärimaa M; Söderström KO; Kalimo H; Inberg M; Nevalainen T
    Scand J Gastroenterol; 1984 Sep; 19(6):787-97. PubMed ID: 6515317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.